Cat: IPD-X26195

Recombinant Mouse THSD7A Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    THSD7A

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 种属

    Mouse

  • 表达系统

    E. coli

  • 标签

    N-His

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q69ZU6

  • 表达区间

    Thr42~Tyr242

  • 分子量

    27kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

THSD7A (Thrombospondin Type 1 Domain Containing 7A) is a protein that plays a crucial role in various biological processes, including cell adhesion, migration, and extracellular matrix interactions. The interest in THSD7A has grown significantly due to its involvement in certain diseases, particularly in the context of autoimmune conditions and cancer. Research has identified THSD7A as a potential autoantigen in diseases such as thrombocytopenic purpura and has linked it to the regulation of angiogenesis and tumor progression. The recombinant expression of THSD7A offers a valuable tool for elucidating its biological functions and interactions. By producing THSD7A in a controlled environment, researchers can investigate its structure-function relationships, explore its role in cellular pathways, and assess its potential as a biomarker for diagnostic purposes or as a target for therapeutic interventions. The study of THSD7A also contributes to a broader understanding of the molecular mechanisms underpinning disease pathology, making it a significant focus of ongoing biomedical research. Advances in recombinant protein technology facilitate the large-scale production of THSD7A, enabling detailed biophysical characterization and application in experimental models. Overall, the exploration of THSD7A and its recombinant protein forms holds promise for enhancing our understanding of various diseases and developing innovative therapeutic strategies.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US